Angiotech To Commence Cash Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior...
Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, today announced the commencement of a cash tender offer of the outstanding notes listed below in an amount that will result in an aggregate purchase price of $165 million for all Notes purchased.
 

More

  • CHOCOLATE CANDY CREATIONS, INC. (form S-1)

    CHOCOLATE CANDY CREATIONS, INC. Files SEC form S-1, Securities Registration Statement

  • Rexahn Pharmaceuticals Receives AMEX Listing Approval (Business Wire)

    ROCKVILLE, Md.----Rexahn Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for cancer, central nervous system disorders, sexual dysfunction and other unmet medical needs, announced today that its common shares have been approved for listing on the American Stock Exchange and are expected to commence trading at the opening of the market on Tuesday, May 27, 2008.